Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
to underpin Salmonella pathogenesis. The post-holder will be responsible for managing their own academic research programme in Salmonella effector biology. You will have a high degree of autonomy to develop
-
own research and administrative activities, and contribute to wider project planning. The post-holder must have a first degree in Biochemistry, Molecular Biology or related biomedical sciences with
-
will hold or be close to completion of a relevant first degree. You will need to undertake experimental research and collect, analyse and present data, working in collaboration with a post-doctoral
-
. Richard Walker, Principal Investigator on the project. The successful candidate will work closely with Prof. Richard Walker, along with the broader COMET community, on a project sponsored by the UK Foreign
-
encouraged to apply. The applicant must be able to demonstrate a high level of competence in experimental lab-based research. *Please note that ‘near completion’ means that your PhD thesis has been submitted
-
to evaluate and stress-test LLM agents in system-level environments. Studying adversarial threats and hijack scenarios. Developing practical safeguards and certification strategies to ensure safe execution
-
Pay Scale: STANDARD RESEARCH GRADE 7 Salary (£): £41,997 - £46,913 per annum Location: Department of Biochemistry, South Parks Road, Oxford Contract type: Fixed Term contract for up to 3 years in
-
for 1 year with a possible extension. Reporting to the Principal Investigator, you will help ensure a healthy and vibrant research environment within the VGG. This will involve conducting research in deep
-
risks to aircraft engines. The Particles Research Group works on icing problems closely with industrial partners, is currently developing a new altitude icing wind tunnel and entering a new EPSRC
-
(TB). The main aims of OxCoD4TB are to establish and validate a new TB therapeutics pipeline and discover and evaluate novel compounds and also drug and vaccine combinations. Over the last ten years we